285 related articles for article (PubMed ID: 30879245)
41. Psychosocial interventions for preventing and treating depression in dialysis patients.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
[TBL] [Abstract][Full Text] [Related]
42. Dietary Intake and Diabetic Retinopathy: A Systematic Review of the Literature.
Shah J; Cheong ZY; Tan B; Wong D; Liu X; Chua J
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501054
[TBL] [Abstract][Full Text] [Related]
43. How the diabetic eye loses vision.
Davidson JA; Ciulla TA; McGill JB; Kles KA; Anderson PW
Endocrine; 2007 Aug; 32(1):107-16. PubMed ID: 17992608
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and Severity of Diabetic Retinopathy in Patients with Macular Telangiectasia Type 2.
van Romunde SHM; van der Sommen CM; Martinez Ciriano JP; Vingerling JR; Yzer S
Ophthalmol Retina; 2021 Oct; 5(10):999-1004. PubMed ID: 33444807
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of and Risk Factors for Diabetic Retinopathy and Diabetic Macular Edema in Patients with Early- and Late-Onset Diabetes Mellitus.
Wang Y; Lin Z; Zhai G; Ding XX; Wen L; Li D; Zou B; Feng KM; Liang YB; Xie C
Ophthalmic Res; 2022; 65(3):293-299. PubMed ID: 32353847
[TBL] [Abstract][Full Text] [Related]
46. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy.
Meer E; Bavinger JC; Yu Y; VanderBeek BL
JAMA Ophthalmol; 2022 May; 140(5):529-532. PubMed ID: 35389455
[TBL] [Abstract][Full Text] [Related]
47. The effect of psychotherapy on anxiety, depression, and quality of life in patients with diabetic retinopathy: A protocol for systematic review and network meta-analysis.
Li S; Liu H; Zhu X
Medicine (Baltimore); 2021 Dec; 100(51):e28386. PubMed ID: 34941170
[TBL] [Abstract][Full Text] [Related]
48. Impact of estimated glomerular filtration rate on diabetic macular edema.
Temkar S; Karuppaiah N; Takkar B; Bhowmik D; Tripathi M; Ramakrishnan S; Sharma YR; Vohra R; Chawla R; Venkatesh P
Int Ophthalmol; 2018 Jun; 38(3):1043-1050. PubMed ID: 28523527
[TBL] [Abstract][Full Text] [Related]
49. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
[TBL] [Abstract][Full Text] [Related]
50. Validation of a novel diabetic retinopathy utility index using discrete choice experiments.
Fenwick EK; Bansback N; Gan ATL; Ratcliffe J; Burgess L; Wong TY; Lamoureux EL
Br J Ophthalmol; 2020 Feb; 104(2):188-193. PubMed ID: 31097442
[TBL] [Abstract][Full Text] [Related]
51. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
[TBL] [Abstract][Full Text] [Related]
52. Impact of diabetic retinopathy on vision-specific function.
Lamoureux EL; Tai ES; Thumboo J; Kawasaki R; Saw SM; Mitchell P; Wong TY
Ophthalmology; 2010 Apr; 117(4):757-65. PubMed ID: 20122736
[TBL] [Abstract][Full Text] [Related]
53. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and risk factors for diabetic retinopathy in a cross-sectional population-based study from rural southern China: Dongguan Eye Study.
Cui Y; Zhang M; Zhang L; Zhang L; Kuang J; Zhang G; Liu Q; Guo H; Meng Q
BMJ Open; 2019 Sep; 9(9):e023586. PubMed ID: 31530585
[TBL] [Abstract][Full Text] [Related]
55. Assessment of quality of life of the patients with diabetic retinopathy using National Eye Institute Visual Functioning Questionnaire (VFQ-25).
Pawar S; Parkar A; Menon S; Desai N; Namrata D; Dole K
J Healthc Qual Res; 2021; 36(4):225-230. PubMed ID: 33820745
[TBL] [Abstract][Full Text] [Related]
56. The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.
Scanlon PH; Loftus J; Starita C; Stratton IM
Diabet Med; 2015 Jan; 32(1):97-101. PubMed ID: 25251842
[TBL] [Abstract][Full Text] [Related]
57. Baseline Diabetic Retinopathy Severity and Time to Diabetic Macular Edema Resolution with Ranibizumab Treatment: A Meta-Analysis.
Talcott KE; Valentim CCS; Hill L; Stoilov I; Singh RP
Ophthalmol Retina; 2023 Jul; 7(7):605-611. PubMed ID: 36774994
[TBL] [Abstract][Full Text] [Related]
58. Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham.
Loftus JV; Sultan MB; Pleil AM;
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7498-505. PubMed ID: 21896838
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of and risk factors for diabetic macular edema in the United States.
Varma R; Bressler NM; Doan QV; Gleeson M; Danese M; Bower JK; Selvin E; Dolan C; Fine J; Colman S; Turpcu A
JAMA Ophthalmol; 2014 Nov; 132(11):1334-40. PubMed ID: 25125075
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
